TPST
Tempest Therapeutics Inc
NASDAQ: TPST · HEALTHCARE · BIOTECHNOLOGY
$1.74
+2.96% today
Updated 2026-04-29
Market cap
$24.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.33
Dividend yield
—
52W range
$2 – $12
Volume
0.2M
Tempest Therapeutics Inc (TPST) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.16M | $-18.09M | $-30.59M | $-50.29M | $-61.73M | $-20.34M | $-23.65M | $-41.22M | $-19.02M | $-25.96M | $-31.07M | $-27.36M | $-33.03M | $-26.82M |
| Capital expenditures | $849000.00 | $719000.00 | $2.80M | $5.23M | $2.59M | $4000.00 | $36000.00 | $397000.00 | $50000.00 | $135000.00 | $562000.00 | $170000.00 | $435000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.38M | $5.09M | $12.41M | $19.34M | $9.21M | $6.89M | $1.43M | $310000.00 | $453000.00 | $1.10M | $1.56M | $2.55M | $5.30M | $3.12M |
| Free cash flow | $-12.01M | $-18.81M | $-33.39M | $-55.52M | $-64.32M | $-20.34M | $-23.68M | $-41.62M | $-19.07M | $-26.09M | $-31.63M | $-27.53M | $-33.46M | $-26.82M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |